Kamada Ltd. Plans Dividend of $0.20 (NASDAQ:KMDA)

Kamada Ltd. (NASDAQ:KMDA) declared a dividend on Wednesday, March 5th, NASDAQ Dividends reports. Investors of record on Monday, March 17th will be given a dividend of 0.20 per share by the biotechnology company on Monday, April 7th. The ex-dividend date is Monday, March 17th.

Kamada Price Performance

KMDA stock traded up $0.09 during trading on Friday, reaching $7.41. The company had a trading volume of 266,599 shares, compared to its average volume of 264,311. Kamada has a 52 week low of $4.74 and a 52 week high of $9.15. The business has a 50 day moving average of $7.10 and a 200 day moving average of $6.15. The company has a market cap of $425.93 million, a P/E ratio of 26.46, a PEG ratio of 0.97 and a beta of 0.99.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reaffirmed a “buy” rating and set a $11.00 target price on shares of Kamada in a research note on Thursday.

Kamada Company Profile

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite.